Alzheimer's Disease News and Research

RSS

Alzheimer's disease (AD) is an irreversible, progressive brain disease that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks of daily living. In most people with AD, symptoms first appear after age 60. AD is the most common cause of dementia among older people, but it is not a normal part of aging. Dementia refers to a decline in cognitive function that interferes with daily life and activities. AD starts in a region of the brain that affects recent memory, then gradually spreads to other parts of the brain. Although treatment can slow the progression of AD and help manage its symptoms in some people, currently there is no cure for this devastating disease.

UofL researchers receive $11.7 million to study microorganisms throughout the body

University of Louisville researchers have received $11.7 million to study microorganisms throughout the body, including the mouth. What they find could lead to better understanding and treatment of a range of chronic conditions.

25 Aug 2023

New 3D model mimics brain cell and immune cell interactions in Alzheimer's disease

Cognitive decline associated with Alzheimer's disease (AD) develops when neurons begin to die, which can be caused by inappropriate immune responses and excessive inflammation in the brain triggered by amyloid beta deposits and tau tangles, two hallmarks of the disease.

25 Aug 2023

Cardio or cerebrovascular mortality of AF patients has declined in the UK over 16 years

Patients living with one of the UK's most common heart rhythm conditions are 50% less likely to die from a heart attack or stroke than they were at the start of the millennium, new research has found.

25 Aug 2023

UK Biobank Dementia Risk Score outperforms other widely used scores

A new dementia risk score, which draws on 11 mostly modifiable risk factors, identifies people at risk—from mid-life onwards—of developing the disease within the next 14 years, suggests a large long-term study published in the open access journal BMJ Mental Health.

25 Aug 2023

Certain gut conditions associated with higher risk of Parkinson's disease diagnosis

Certain gut problems, such as constipation, difficulty swallowing, and irritable bowel syndrome (IBS), may be early warning signs of the neurological condition Parkinson's disease, suggests research published online in the journal Gut.

24 Aug 2023

Engineered adeno-associated virus vector yields high transduction of the brain vasculature

Researchers have developed an engineered adeno-associated virus (AAV) vector that yields high transduction of brain vascular pericytes and smooth muscle cells.

24 Aug 2023

Small molecule inhibitor of the NLRP3 inflammasome for treating autoinflammatory diseases

Researchers described the preclinical profile of JT002, a novel and orally bioavailable small molecule inhibitor of the NLRP3 inflammasome.

24 Aug 2023

The most recent neuroimaging procedures and machine learning approaches for the prediction of Alzheimer’s progression

Researchers examined recent studies exploring neuroimaging modalities aided by advanced machine learning (ML) algorithms.

24 Aug 2023

41% of people with post-viral syndrome had evidence of SARS-CoV-2 exposure

Millions of Americans were exposed to SARS-CoV-2, the virus that causes COVID-19, early in the pandemic but could not get diagnosed due to testing limitations.

23 Aug 2023

New study to investigate link between agricultural fire smoke and dementia risk

Worldwide, the practice of preparing agricultural fields by burning crop residue contributes large quantities of gaseous pollutants and aerosol particles to the atmosphere and is a known cardiorespiratory health hazard.

23 Aug 2023

New digital biomarker could detect Alzheimer's disease in its earliest stages

Researchers from the University of Colorado Anschutz Medical Campus and Washington University in St. Louis have identified a way to assess brain activity in sleep that occurs in the earliest stages of Alzheimer's disease, typically many years prior to developing symptoms of dementia.

23 Aug 2023

UT Health San Antonio and partners secure NIH funding to translate scientific discoveries into therapeutic benefits

The University of Texas Health Science Center at San Antonio (also called UT Health San Antonio) and seven regional collaborators will leverage $46 million from the National Institutes of Health (NIH) over the next five to seven years to translate scientific discoveries into therapeutic benefits for human health and well-being.

22 Aug 2023

Max Planck Florida receives NIH funding to investigate the neural circuits underlying Alzheimer's disease

Max Planck Florida will be able to expand their research program to investigate the neural circuits underlying Alzheimer's disease with new support.

22 Aug 2023

Study shows link between regulatory T cells and anxiety, depression, Alzheimer's disease

Regulatory T cells - work horses of the body's immune system - may also stabilize mood, according to a study. Forkhead box P3 (Foxp3) is a transcription factor that controls the production of regulatory T cells (Tregs).

22 Aug 2023

Genetically diverse mouse models offer new insights into Alzheimer's disease

A new study by Indiana University School of Medicine researchers uses more genetically diverse mouse models to study the accumulation and spread of abnormal tau protein deposits in the brain - a known sign of Alzheimer's disease and several other neurodegenerative diseases.

22 Aug 2023

Alzheimer's Disease News and Research

Further Reading

UofL researchers receive $11.7 million to study microorganisms throughout the body

New 3D model mimics brain cell and immune cell interactions in Alzheimer's disease

Cardio or cerebrovascular mortality of AF patients has declined in the UK over 16 years

UK Biobank Dementia Risk Score outperforms other widely used scores

Certain gut conditions associated with higher risk of Parkinson's disease diagnosis

Engineered adeno-associated virus vector yields high transduction of the brain vasculature

Small molecule inhibitor of the NLRP3 inflammasome for treating autoinflammatory diseases

The most recent neuroimaging procedures and machine learning approaches for the prediction of Alzheimer’s progression

41% of people with post-viral syndrome had evidence of SARS-CoV-2 exposure

New study to investigate link between agricultural fire smoke and dementia risk

New digital biomarker could detect Alzheimer's disease in its earliest stages

UT Health San Antonio and partners secure NIH funding to translate scientific discoveries into therapeutic benefits

Max Planck Florida receives NIH funding to investigate the neural circuits underlying Alzheimer's disease

Study shows link between regulatory T cells and anxiety, depression, Alzheimer's disease

Genetically diverse mouse models offer new insights into Alzheimer's disease

The relationship between breast milk feeding and infants’ neurodevelopment via epigenetics

Platelets play a role in mediating the rejuvenating effects of exercise during physiological brain ageing

The growing role of AI in science and discovery

Time-restricted feeding may correct the circadian disruptions in Alzheimer's disease

Sleep dysfunction is underreported and underrecognized in Huntington's disease

Industry Focus eBook - Neurology/Neuroscience - 2nd edition eBook

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News